St. Jude Medical

(STJ)

reported fourth-quarter earnings today that met Wall Street's slightly lowered estimates.

For the fourth quarter ended Dec. 31, St. Jude earned $41.1 million, or 47 cents a diluted share, up from $36.1 million, or 43 cents a share, in the year-ago period. Twenty-seven analysts polled by

First Call/Thomson Financial

expected the medical devices maker, which is based in St. Paul, Minn., to report 47 cents a share.

St. Jude posted fourth-quarter sales of $295.4 million, up from $281.3 million in the same quarter one year ago.

Shares of St. Jude fell 95 cents, or 1.5%, to $62.55 in recent

New York Stock Exchange

trading.